Sipuleucel - T is a vaccine for:: (A) RCC, (B) Testicular tumor, (C) Carcinoma prostate, (D) Carcinoma bladder
Answer is C. In prostate cancer, several immunologic strategies have been under clinical development. The most impoant of these include the sipuleucel-T(Provenge) autologous prostatic acid phosphates (PAP) - loaded dendritic cell vaccine, the GVAX allogeneic recombinant whole cell vaccine, and CTLA-4 inhibitory approaches.